Intelligent Medicine Acquisition Overview
Intelligent Medicine Acquisition (IQMD) has a P/E ratio of 22.53, below the sector sector average of 47.3.
Get informed when a big investor buys or sells
+ Follow22.53
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, IQMD shows a P/E ratio of 22.53. That is below the sector sector average of 47.3. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 47.3. Intelligent Medicine Acquisition is at 22.53, which is lower that average. That is roughly 52.4% below the sector mean. Use the comparison chart on this page to see how IQMD stacks up against individual peers as well.
Investors watch IQMD's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Intelligent Medicine Acquisition's latest reading is 22.53. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Intelligent Medicine Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 22.53) with ownership activity and broader fundamentals.
